NHS 'not ready' for weight loss drugs
A weight loss programme in North Cumbria can prescribe weight loss drugs like Ozempic to 10% of patients due to strict eligibility criteria.
A webinar hosted by Pears Cumbria Medical School discussed obesity, weight management, and appetite suppressing drugs like Ozempic and Mounjaro.
These drugs are known as GLP-1 agonists, simulating the effect of the GLP-1 hormone, naturally produced in the body after eating.
Doctor Ishara Ranathunga reported a rise in demand for the NHS weight loss programme, with 3,274 patients since 2024 and over 3,740 referrals.
Author's summary: NHS faces challenges with weight loss drugs.
More News
- Common Drugs Can Rewire Your Gut For Several Years, Study Finds
- Kansas State football's blunders vs Texas Tech reminds of season's frustrations | Wheeler
- Home record alive as Phoenix take down Wildcats
- Police rule out terrorism in stabbing attack on UK train after 2 men are arrested
- Donald Trump slams Seth Meyers again, calling him “The Least Talented Person on TV” | Al Bawaba
- John Travolta Proves He’s Still Got the Moves with a Legendary Dance Lesson on The Late Late Show